In short. The named indications each material is approved for, and everything that lies outside them, including general cosmetic use.
Key points
- That a material is approved for one thing is a checkable fact.
- That it is used for another is common and may be reasonable.
- What is not reasonable is citing the first to support the second, because the assessment was carried out for the indication the approval names.
Approval in this category is attached to a material and an indication, and the most common confusion in the field is between an approval that exists and the use it is cited to support.
The named indication
The clearest approval in this group covers facial fat loss associated with a specific illness. The material was assessed for that purpose, in that population, and the authorisation says so. It is a genuine approval and a meaningful one, because the condition it addresses is a specific clinical problem with a defined population. It is also narrower than the way the material is usually described in cosmetic practice, where the same product is offered for general facial volume and appearance.
What lies outside it
General rejuvenation, skin quality improvement, tightening of loose skin and use at sites other than the one assessed are all outside that indication. Using a material outside its indication is not improper by itself: off-label use is routine across medicine, and it is how many treatments are developed in the first place. What it means is that the evidence behind the new use is thinner than for the approved one, because nobody was required to demonstrate it for the new purpose, and the studies that would do so are the studies that have not been run.
An approval is a fact; a use is a decision
That a material is approved for one thing is a checkable fact. That it is used for another is common and may be reasonable. What is not reasonable is citing the first to support the second, because the assessment was carried out for the indication the approval names.
The absence of a reversal agent
This is the regulatory fact with the largest practical consequence. No approved agent dissolves these materials. A hyaluronic acid filler can be broken down with an enzyme if a result is unwanted or a complication occurs, which makes an unsatisfactory outcome a problem that can be addressed. For the materials in this group, that option does not exist, and the permanence is a property of the material rather than of the clinic or the technique.
Differences between markets
What a material is authorised for, and by which route, differs between jurisdictions. A product available and approved for a named indication in one market may have a different status, a different indication or no authorisation at all in another, and an injectable that is a regulated device in one country may be regulated as a medicine in the next. Because the routes differ, a regulatory statement is incomplete unless it names the authority, the market and the indication.
Three questions about a material's status
- What is it approved for here, by which authority, and does the proposed use sit inside that?
- If the use is outside the indication, what evidence exists for it and how strong is it?
- Is there any agent that reverses it, and if not, what happens if the result is unwanted?
Approval tells you what was demonstrated for one purpose. It does not tell you what the material will do for you, and the difference between those questions is what the rest of this site is about.
Frequently asked questions
What is a collagen stimulator approved for?
It depends on the material and the market. The clearest named indication in this group is facial fat loss associated with a specific illness, where the material was assessed for that use. General cosmetic rejuvenation is a different purpose and sits outside what that approval covers.
Is off-label use of these materials common?
It is widespread, as it is across medicine. Using a material outside its named indication is not by itself improper, and it does mean the evidence behind the new use is thinner than for the approved one, because the studies that would establish it for the new purpose have not been required.
Why can the material not be dissolved?
Because no approved agent breaks it down. A hyaluronic acid filler has an enzyme that can be used to dissolve it, which is why an unwanted result with one of those is a problem that can be addressed. The materials in this group have no such agent, and that difference is a regulatory and practical fact rather than a matter of degree.
Risks & Limitations
- Nothing reverses these materials: no approved agent dissolves them, so a result that is unwanted cannot be injected away.
- Lumps can form around the injected material, more readily in some sites and materials than others, and they cannot be dissolved.
- A named approval covers facial fat loss after an illness, and general cosmetic use sits outside it.
- Histology shows a tissue response; how much visible change it produces is a separate question the studies were not designed to answer.
- The change develops over months, so a person commits to further treatment before knowing how their own tissue responds to the first injection.
When to Seek Care
- A lump, firmness or discolouration in a treated area — have it assessed by a clinician.
- Persistent pain, or skin that is changing colour or blistering after an injection.
- Any change in vision, or severe pain around the eye — seek emergency care immediately.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — approved injectable devices and their named indications
- European Medicines Agency (EMA) and national regulators — dermal filler and injectable safety communications
- National Medical Products Administration (NMPA, China) — approved injectable products and their indications
- Cochrane Library — systematic reviews of injectable treatments for facial volume loss
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.